Arsenal Bio, one of the few cell therapy companies able to raise significant capital amid a prolonged downturn, has laid just ...

A meeting of health secretary Robert F. Kennedy Jr., and anti-vaccine campaigner David Geier with leaders of the country’s ...

A Wednesday Senate hearing aimed to answer questions about the exodus of top leaders from the CDC last month. Instead, it ...

Filed by Rep. Pat Ryan (D-NY), the bill is aimed at breaking up companies like UnitedHealth Group, which has purchased large ...

Sara Carter, formerly of Fox News, argues her firsthand reporting experience qualifies her for a leading role combating drug ...

The outlook for some 3 million people with narcolepsy worldwide could soon improve as drugmakers are racing to win approval ...

CAMBRIDGE, Mass. — Biogen on Tuesday held a ceremonial groundbreaking of its 16-story headquarters in Kendall Square, ...

U.K.-based drugmaker GSK said it planned to invest $30 billion in the U.S. over five years, an announcement timed to this ...

In a climate of fear CDC scientists are withdrawing names from papers, and local and global health agencies are losing ...

Amid concern about Americans’ access to vaccines, a major health insurance association said member plans will continue to ...

In a late-stage trial, an investigational GLP-1 pill from Eli Lilly helped diabetes patients lower their blood sugar and ...

President Trump, who has said European countries need to pay more for medicines, is in the U.K. this week, as a spat over ...